(Q44629818)

4 December 2017

title

Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate (English)

1 reference

4 December 2017

1 reference

Madhavi Kolli

1

1 reference

4 December 2017

Stephane Lastere

series ordinal

2

1 reference

4 December 2017

Celia A Schiffer

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

20 January 2006

1 reference

4 December 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

4 December 2017

volume

347

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

405-409

1 reference

Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Covariation of amino acid positions in HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Nelfinavir mesylate: a protease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Structure-based inhibitors of HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

inferred from DOI database lookup

7 January 2021

based on heuristic

Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.049

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2005.11.049

1 reference

4 December 2017

1 reference